Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 19, 2022 - Issue 1

Submit an article Journal homepage

Open access

5,817

Views

CrossRef citations to date

Altmetric

Research Articles

Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety

Samy SuissaCentre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, CanadaCorrespondence[email protected]

https://orcid.org/0000-0002-1281-5296

Sophie Dell’AnielloCentre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

Pierre ErnstCentre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

https://orcid.org/0000-0001-9983-3608

Pages 109-117 | Received 29 Oct 2021, Accepted 22 Jan 2022, Published online: 06 Apr 2022

Cite this article
https://doi.org/10.1080/15412555.2022.2035705
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daiana Stolz, Erik Hermansson, Mario Ouwens, Barinder Singh, Akanksha Sharma, Dan Jackson, Patrick Darken, Jonathan Marshall, Karin Bowen, Hana Müllerová, Bernardino Alcázar Navarrete, Richard Russell, MeiLan K. Han & Deniz Tansey-Dwyer. (2023) Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT. Current Medical Research and Opinion 0:0, pages 1-11.
Read now

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references